Edition:
United States

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

9.64USD
19 Oct 2018
Change (% chg)

$0.02 (+0.21%)
Prev Close
$9.62
Open
$9.61
Day's High
$10.30
Day's Low
$9.54
Volume
113,330
Avg. Vol
57,117
52-wk High
$17.39
52-wk Low
$7.21

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 2.03 -0.194
Mar '18 1.46 -0.202
FY 2017 Dec '17 16.42 0.073
Sep '17 1.07 -0.154
Jun '17 0.75 -0.216
Mar '17 2.01 -0.166
FY 2016 Dec '16 1.43 -0.124
Sep '16 1.33 -0.169
Jun '16 19.96 0.240
Mar '16 0.49 -0.114
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 1.87 3.73 0.00 --
Year Ending Dec-18 2 5.97 8.44 3.50 25.46
Year Ending Dec-19 2 9.60 19.19 0.00 14.47
Earnings (per share)
Quarter Ending Dec-18 2 -0.27 -0.23 -0.31 --
Year Ending Dec-18 2 -0.91 -0.86 -0.96 -0.74
Year Ending Dec-19 2 -0.95 -0.89 -1.02 -0.91
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta -- 0.63 0.87
Price to Sales (TTM) 23.01 109.82 6.55
Price to Book (MRQ) 4.38 13.72 4.00
Price to Tangible Book (MRQ) 5.06 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 169.32 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago 279.95 91.25 6.56
Sales - 5 Yr. Growth Rate -- 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 10.20 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago 29.24 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -- 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 9.65 5.52 2.99
LT Debt to Equity (MRQ) 0.58 15.33 11.31
Total Debt to Equity (MRQ) 0.58 18.80 14.15
Interest Coverage (TTM) -13.70 -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) -136.11 -- --
EBITD - 5 Yr. Avg -- -164.07 16.13
Operating Margin (TTM) -139.84 -618.88 3.36
Operating Margin - 5 Yr. Avg. -- -178.92 11.28
Pre-Tax Margin (TTM) -130.52 -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -- -181.48 11.54
Net Profit Margin (TTM) -130.52 -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -- -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 245,809 24,741,437 725,680,242
Net Income/Employee (TTM) -320,825 1,102,410 84,001,075
Receivable Turnover (TTM) 11.31 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.17 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -22.46 0.35 9.83
Return on Assets - 5 Yr. Avg. -- 3.11 10.94
Return on Investment (TTM) -24.17 1.96 12.83
Return on Investment - 5 Yr. Avg. -- 2.91 14.05
Return on Equity (TTM) -25.32 1.12 14.95
Return on Equity - 5 Yr. Avg. -- -0.97 15.39
  1 Year 3 Year 5 Year
Sales % -12.75 -12.53 --
EPS (TTM) % -226.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AC Immune SA

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 18.30%
# of Holders: 23
Total Shares Held: 12,127,165
3 Mo. Net Change: 189,577
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.